Total Funding
37
60
Total FundingSeed raised
Growth Score
-1 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
92626
Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines.
Mark Burk: Founder, President & CEOPast Role: Genomatica, Chief Technology Officer- Kent Boles: Co-founder and Head of R&DPast Role: DeepDiveBio, Inc., CTO
About the Company
Lassogen is a biotechnology company exploring lasso peptides as a way to develop new medicines.
Lassogen was founded in 2019 to unlock the full potential of lasso peptides as a new therapeutic modality for diagnosing and treating some of our most intractable health challenges. The company is the result of a convergence of technological advances
that have opened the door to a vast, new, untapped source of novel medicines.
